ZEB1 and ovarian carcinoma: It has been shown that NEAT1 expression level is upregulated in chemoresistant ovarian cancer tissues; NEAT1 knockdown increases the chemosensitivity of ovarian cancer cells to paclitaxel both in vivo and in vitro via the NEAT1/miR-194/ZEB1 axis (An et al., 2017[4]).